{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:38:58Z","timestamp":1760143138515,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Remote ischemic preconditioning (RIPC) has demonstrated efficacy in protecting against myocardial ischemia\u2013reperfusion injury when applied before percutaneous coronary revascularization. Ranolazine, an anti-ischemic drug, has been utilized to minimize ischemic events in chronic angina patients. However, there is a lack of trials exploring the combined effects of ranolazine pretreatment and RIPC in patients undergoing percutaneous coronary interventions (PCIs). Materials and Methods: The present study is a prospective study which enrolled 150 patients scheduled for nonemergent percutaneous coronary revascularization. Three groups were formed: a control group undergoing only PCIs, an RIPC group with RIPC applied to either upper limb before the PCI (preconditioning group), and a group with RIPC before the PCI along with prior ranolazine treatment for stable angina (ranolazine group). Statistical analyses, including ANOVAs and Kruskal\u2013Wallis tests, were conducted, with the Bonferroni correction for type I errors. A repeated-measures ANOVA assessed the changes in serum enzyme levels (SGOT, LDH, CRP, CPK, CK-MB, troponin I) over the follow-up. Statistical significance was set at p &lt; 0.05. Results: The ranolazine group showed (A) significantly lower troponin I level increases compared to the control group for up to 24 h, (B) significantly lower CPK levels after 4, 10, and 24 h compared to the preconditioning group (p = 0.020, p = 0.020, and p = 0.019, respectively) and significantly lower CPK levels compared to the control group after 10 h (p = 0.050), and (C) significantly lower CK-MB levels after 10 h compared to the control group (p = 0.050). Conclusions: This study suggests that combining RIPC before scheduled coronary procedures with ranolazine pretreatment may be linked to reduced ischemia induction, as evidenced by lower myocardial enzyme levels.<\/jats:p>","DOI":"10.3390\/medicina60010166","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:56:59Z","timestamp":1705381019000},"page":"166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention"],"prefix":"10.3390","volume":"60","author":[{"given":"Konstantinos","family":"Kourtis","sequence":"first","affiliation":[{"name":"Department of Cardiology, Konstantopouleio General Hospital, 14233 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Bourazana","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-3946","authenticated-orcid":false,"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Skoularigkis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Papadakis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Konstantopouleio General Hospital, 14233 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Patsilinakos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Konstantopouleio General Hospital, 14233 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-2478","authenticated-orcid":false,"given":"John","family":"Skoularigis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jss.2007.12.747","article-title":"Remote ischemic preconditioning: A novel protective method from ischemia reperfusion injury\u2014A review","volume":"150","author":"Tapuria","year":"2008","journal-title":"J. Surg. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1253\/circj.CJ-17-1000","article-title":"Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients with Complex Coronary Lesions\u2014Subanalysis of a Randomized Controlled Trial","volume":"82","author":"Ejiri","year":"2018","journal-title":"Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e009058","DOI":"10.1161\/JAHA.118.009058","article-title":"Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function","volume":"7","author":"Lau","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1074248411409040","article-title":"Remote ischemic preconditioning: Current knowledge, unresolved questions, and future priorities","volume":"16","author":"Przyklenk","year":"2011","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/clc.22425","article-title":"Effects of Ranolazine in Patients with Chronic Angina in Patients with and without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations from the MERLIN-TIMI 36 Trial","volume":"38","author":"Gutierrez","year":"2015","journal-title":"Clin. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2022.01.049","article-title":"Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention","volume":"353","author":"Zhao","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.04.042","article-title":"The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease","volume":"56","author":"Stone","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","unstructured":"Reed, M., Kerndt, C.C., Gopal, S., and Nicolas, D. (2023, November 01). Ranolazine, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507828\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcin.2014.05.015","article-title":"Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction","volume":"8","author":"White","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ahj.2012.03.018","article-title":"A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention","volume":"163","author":"Pelliccia","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial","volume":"375","author":"Botker","year":"2010","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4244\/EIJV9I12A244","article-title":"Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: A meta-analysis of randomised clinical trials","volume":"9","author":"Moretti","year":"2014","journal-title":"EuroIntervention"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/ehq393","article-title":"Peri-procedural myocardial injury during percutaneous coronary intervention: An important target for cardioprotection","volume":"32","author":"Babu","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCULATIONAHA.105.593210","article-title":"Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound","volume":"114","author":"Porto","year":"2006","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention","volume":"364","author":"Prasad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.0000156328.28485.AD","article-title":"Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging","volume":"111","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"C940","DOI":"10.1152\/ajpcell.1990.259.6.C940","article-title":"Na-H exchange in myocardium: Effects of hypoxia and acidification on Na and Ca","volume":"259","author":"Anderson","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.RES.0000187456.06162.cb","article-title":"Cardiac-specific ablation of the Na+-Ca2+ exchanger confers protection against ischemia\/reperfusion injury","volume":"97","author":"Imahashi","year":"2005","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.RES.72.1.112","article-title":"Mechanism of preconditioning. Ionic alterations","volume":"72","author":"Steenbergen","year":"1993","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2011.03.003","article-title":"New drugs vs. old concepts: A fresh look at antiarrhythmics","volume":"132","author":"Thireau","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rouhana, S., Virsolvy, A., Fares, N., Richard, S., and Thireau, J. (2021). Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010031"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:52Z","timestamp":1760104072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["medicina60010166"],"URL":"https:\/\/doi.org\/10.3390\/medicina60010166","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,1,16]]}}}